Join the club for FREE to access the whole archive and other member benefits.

Inside Shift Bioscience’s single-gene rejuvenation breakthrough — Exclusive with CEO Daniel Ives

Daniel Ives discusses Shift Bioscience’s groundbreaking single-gene approach to rejuvenation

The episode kicks off with an introduction to the innovative work of Shift Bioscience—exploring breakthrough strategies that aim to make people feel and even become younger—and a conversation with the company’s founder and CEO, Daniel Ives. 

Key Points:

The episode offers a glimpse into a future where ageing might be reconceived as an ongoing process of renewal. Daniel Ives shares the scientific rationale behind the breakthrough, the challenges of translating lab research into real-world applications, and the potential paradigm shift in longevity science ushered in by Shift Bioscience’s pioneering efforts.

  • Reinventing Ageing: Daniel Ives outlines the vision of Shift Bioscience, which aims to reverse age-related decline so that every day feels like an upgrade towards youthfulness.
  • Personalized Rejuvenation: The company’s approach focuses on targeted interventions, including a unique single-gene strategy, to improve overall well-being rather than merely treating symptoms.
  • Scientific Evolution: Shift’s research journey has evolved from studying mitochondrial function to leveraging mouse epigenetic clocks, ultimately leading to a breakthrough in longevity science.
  • AI-Powered Discoveries: The use of artificial intelligence in simulating cellular behaviour is highlighted as a key tool in identifying novel rejuvenation interventions.
  • Breakthrough Study: Ives discusses a new, publicly unveiled study that represents the cutting edge of regenerative medicine and the promise of the single-gene rejuvenation approach.
  • Building a Better Future: The conversation reveals how a future reality might look where individuals could wake up progressively healthier and even biologically younger with each passing day.
  • Funding Milestone: A recent $16 million fundraising round was disclosed, marking a significant step to scale the innovative research and potential applications.
  • Bridging Theory and Practice: Emphasis is placed on translating complex molecular biology into tangible, practical interventions that could alter the landscape of ageing.

Visit website: https://www.youtube.com/watch?v=vdOVKZ8Q7kg

See also

LEVITY Podcast

Ageing Science and radical life extension podcast with Peter Ottsjö and Ingemar Patrick Linden

Details last updated 19-Jun-2025

Mentioned in this Resource

Daniel Ives

Founder and CEO of Shift Bioscience Limited

Shift Bioscience

Simulation guided cell rejuvenation to defeat the diseases of aging